A PYMNTS Company

All Eyes on Antitrust Enforcement in China’s Pharmaceutical Industry

By  |  August 6, 2016

Posted by Social Science Research Network

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    All Eyes on Antitrust Enforcement in China’s Pharmaceutical Industry

    Adrian Emch & Jiaming Zhang (Hogan Lovells)

    Abstract:      A wide range of recent antitrust enforcement actions in the pharmaceutical sector have taken place in China over the past months. All three Chinese antitrust authorities have been involved, and all types of anti-competitive conduct have been targeted.

    The multiple enforcement actions by a number of regulators put the pharmaceutical sector very clearly into the spotlight. Very few other sectors have seen the same level of antitrustenforcement activism in recent months in China, and there does not seem to be an end in sight to this activism.